Home › Funds › PRIMECAP MANAGEMENT CO/CA/ › ONC
PRIMECAP MANAGEMENT CO/CA/ position in ONC
BEONE MEDICINES LTD · Health Care
PRIMECAP MANAGEMENT CO/CA/ reported holding 4,906,701 shares of ONC (BEONE MEDICINES LTD) in its Q3 2026 13F filing — a position valued at US$1.80B, representing 1.11% of its reported portfolio and ranking #24 among its reported holdings. PRIMECAP MANAGEMENT CO/CA/ has disclosed ONC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How PRIMECAP MANAGEMENT CO/CA/'s ONC position evolved
PRIMECAP MANAGEMENT CO/CA/ first disclosed a stake in ONC in Q3 2023 at 5,008,739 shares (US$900.9M). The position peaked in Q3 2026 at 4,906,701 shares, worth US$1.80B. Across 13 filings, PRIMECAP MANAGEMENT CO/CA/ increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 4,906,701 shares valued at US$1.80B — a reduction of -101,230 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 5.01M | $900.92M | New |
| Q4 2023 | 4.99M | $899.75M | Hold |
| Q1 2024 | 5.00M | $782.24M | Hold |
| Q2 2024 | 4.99M | $711.39M | Hold |
| Q3 2024 | 4.97M | $1.12B | Hold |
| Q4 2024 | 5.10M | $941.82M | Add |
| Q1 2025 | 5.06M | $1.38B | Reduce |
| Q2 2025 | 5.09M | $1.23B | Add |
| Q3 2025 | 5.08M | $1.73B | Hold |
| Q4 2025 | 4.98M | $1.51B | Reduce |
| Q1 2026 | 4.98M | $1.48B | Hold |
| Q2 2026 | 5.01M | $1.43B | Add |
| Q3 2026 | 4.91M | $1.80B | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ONC and 13F data
ONC (BEONE MEDICINES LTD) is a Health Care company. 29 other funds we track also report a position in ONC — the largest reported positions include BAKER BROS. ADVISORS LP (US$2.51B), Temasek Holdings (US$241.0M), Siren, L.L.C. (US$170.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ONC
- BAKER BROS. ADVISORS LP 8.80M sh · $2.51B · Q2 2026
- Temasek Holdings 845.73K sh · $241.01M · Q2 2026
- Siren, L.L.C. 465.00K sh · $170.16M · Q3 2026
- Candriam S.C.A. 289.24K sh · $106.23M · Q3 2026
- Capital International, Inc./CA/ 290.16K sh · $106.18M · Q3 2026
- Capital International Sarl 206.19K sh · $75.45M · Q3 2026
More on PRIMECAP MANAGEMENT CO/CA/
FAQ
How long has PRIMECAP MANAGEMENT CO/CA/ held ONC?
PRIMECAP MANAGEMENT CO/CA/ has disclosed ONC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is PRIMECAP MANAGEMENT CO/CA/'s current position in ONC?
As of Q3 2026, PRIMECAP MANAGEMENT CO/CA/ holds 4.91M shares of ONC (BEONE MEDICINES LTD), valued at $1.80B, representing 1.11% of its reported portfolio and ranking #24.
Has PRIMECAP MANAGEMENT CO/CA/ been buying or selling ONC?
In the latest 13F filing (Q3 2026), PRIMECAP MANAGEMENT CO/CA/ reduced its position in ONC. The position peaked in Q3 2026 at 4.91M shares.
Which other funds hold ONC?
Other major institutional holders of ONC include BAKER BROS. ADVISORS LP, Temasek Holdings, Siren, L.L.C., among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.